Wright Investors Service’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Wright Investors Service’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-8,288	Closed	-$447K	–	222
2017 Q4	$447K	Sell	8,288 -9,544	-54%	-$522K	0.15%	149
2017 Q3	$1.02M	Buy	17,832 +1,127	+7%	+$66K	0.37%	78
2017 Q2	$1M	Buy	16,705 +6,800	+69%	+$387K	0.38%	70
2017 Q1	$539K	Buy	+9,905	New	+$488K	0.22%	140

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Wright Investors Service's BIVV Position: Q1 2018 in Review

Wright Investors Service sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 8,288 shares — an estimated $447K sold.

Wright Investors Service first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.02M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Wright Investors Service reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Wright Investors Service sold 8,288 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $447K.
Wright Investors Service first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Wright Investors Service's Bioverativ Inc. Common Stock position peaked at $1.02M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Wright Investors Service's 13F filing for Q1 2018, filed 25 Apr 2018.